Lithium succinate

琥珀酸锂

Report date: 2023/10/25 16:28:01
NME

Base Information

Drug NameLithium succinate
Drug Alias NameEfalithEfadermin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell membrane modulators
TargetsNot applicable
Therapy Area/IndicationsDermatitis, Seborrheic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesScotia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScotia
Active IndicationsN/A
Inactive IndicationsDermatitis, Seborrheic

Other Information

ATC CodeD11AX04
Related LinksWikipediaDrugBank